Akoya Biosciences Financials
| AKYA Stock | USD 2.20 0.06 2.80% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.42 | 3.4457 |
|
|
Investors should never underestimate Akoya Biosciences' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Akoya Biosciences' cash flow, debt, and profitability to make informed and accurate decisions about investing in Akoya Biosciences.
Net Income |
|
Akoya | Select Account or Indicator |
Understanding current and past Akoya Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Akoya Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Akoya Biosciences' assets may result in an increase in income on the income statement.
Akoya Biosciences Earnings Geography
Please note, the presentation of Akoya Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Akoya Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Akoya Biosciences' management manipulating its earnings.
Akoya Biosciences Stock Summary
Akoya Biosciences competes with Profound Medical, Si Bone, Nevro Corp, Orthopediatrics Corp, and Orthofix Medical. Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts. Akoya Biosciences operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 319 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US00974H1041 |
| CUSIP | 00974H104 |
| Location | Massachusetts; U.S.A |
| Business Address | 100 Campus Drive, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.akoyabio.com |
| Phone | 855 896 8401 |
| Currency | USD - US Dollar |
Akoya Biosciences Key Financial Ratios
| Return On Equity | -1.28 | ||||
| Profit Margin | (0.65) % | ||||
| Operating Margin | (0.47) % | ||||
| Price To Sales | 1.17 X | ||||
| Revenue | 96.63 M |
Akoya Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Akoya Biosciences's current stock value. Our valuation model uses many indicators to compare Akoya Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Akoya Biosciences competition to find correlations between indicators driving Akoya Biosciences's intrinsic value. More Info.Akoya Biosciences is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At present, Akoya Biosciences' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Akoya Biosciences' earnings, one of the primary drivers of an investment's value.Akoya Biosciences' Earnings Breakdown by Geography
Akoya Biosciences Systematic Risk
Akoya Biosciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Akoya Biosciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Akoya Biosciences correlated with the market. If Beta is less than 0 Akoya Biosciences generally moves in the opposite direction as compared to the market. If Akoya Biosciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Akoya Biosciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Akoya Biosciences is generally in the same direction as the market. If Beta > 1 Akoya Biosciences moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Akoya Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Akoya Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Akoya Biosciences growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Akoya Biosciences December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Akoya Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Akoya Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Akoya Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Akoya Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Akoya Biosciences's daily price indicators and compare them against related drivers.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 40.94 | |||
| Value At Risk | (4.96) | |||
| Potential Upside | 8.59 |
Complementary Tools for Akoya Stock analysis
When running Akoya Biosciences' price analysis, check to measure Akoya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akoya Biosciences is operating at the current time. Most of Akoya Biosciences' value examination focuses on studying past and present price action to predict the probability of Akoya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akoya Biosciences' price. Additionally, you may evaluate how the addition of Akoya Biosciences to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |